Dual use of bladder anticholinergics and cholinesterase inhibitors: Long-term functional and cognitive outcomes

Journal of the American Geriatrics Society

Volumn 56, Issue 5, 2008, Pages 847-853

  Sink, Kaycee M ^a   Thomas III, Joseph ^b,c   Xu, Huiping ^d   Craig, Bruce ^d   Kritchevsky, Steven ^a   Sands, Laura P ^c,e  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Purdue University   (United States)

^d PURDUE UNIVERSITY   (United States)

^e PURDUE UNIVERSITY   (United States)

Author keywords

Anticholinergics; Cholinesterase inhibitors; Dementia; Incontinence; Pharmacotherapy

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; OXYBUTYNIN; RIVASTIGMINE; TACRINE; TOLTERODINE;

ADULT; AGED; ANTICHOLINERGIC EFFECT; ARTICLE; CHOLINERGIC STIMULATION; CLINICAL ASSESSMENT TOOL; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; COMBINATION CHEMOTHERAPY; COMORBIDITY; DAILY LIFE ACTIVITY; DEMENTIA; DETERIORATION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; FEMALE; FUNCTIONAL STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM DATA SET COGNITION SCALE; MONOTHERAPY; NURSING HOME PATIENT; OUTCOME ASSESSMENT; POLYPHARMACY; PROSPECTIVE STUDY; RATING SCALE; SAMPLE SIZE; SIDE EFFECT; UNITED STATES; URINE INCONTINENCE;

ACTIVITIES OF DAILY LIVING; AGED; ALZHEIMER DISEASE; BENZHYDRYL COMPOUNDS; CHOLINERGIC ANTAGONISTS; CHOLINESTERASE INHIBITORS; COGNITION DISORDERS; COHORT STUDIES; CRESOLS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HOMES FOR THE AGED; HUMANS; MALE; MANDELIC ACIDS; NEUROPSYCHOLOGICAL TESTS; NURSING HOMES; PHENYLPROPANOLAMINE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY INCONTINENCE;

EID: 43249100527     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2008.01681.x     Document Type: Article

References (38)

1. Adelmann PK. Prevalence and detection of urinary incontinence among older Medicaid recipients. J Health Care Poor Underserved 2004 15 : 99 112.
2. Hellstrom L, Ekelund P, Milsom I et al. The influence of dementia on the prevalence of urinary and faecal incontinence in 85-year-old men and women. Arch Gerontol Geriatr 1994 19 : 11 20.
3. Carnahan RM, Lund BC, Perry PJ et al. The concurrent use of anticholinergics and cholinesterase inhibitors: Rare event or common practice? J Am Geriatr Soc 2004 52 : 2082 2087.
4. Roe CM, Anderson MJ, Spivack B. Use of anticholinergic medications by older adults with dementia. J Am Geriatr Soc 2002 50 : 836 842.
5. Han L, McCusker J, Cole M et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 2001 161 : 1099 1105.
6. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999 15 : 15 28.
7. Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001 62 (Suppl 21) : 11 14.
8. Edwards KR, O'Connor JT. Risk of delirium with concomitant use of tolterodine and acetylcholinesterase inhibitors. J Am Geriatr Soc 2002 50 : 1165 1166.
9. Siegler EL, Reidenberg M. Treatment of urinary incontinence with anticholinergics in patients taking cholinesterase inhibitors for dementia. Clin Pharmacol Ther 2004 75 : 484 488.
10. Lu CJ, Tune LE. Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry 2003 11 : 458 461.
11. Katz IR, Sands LP, Bilker W et al. Identification of medications that cause cognitive impairment in older people: The case of oxybutynin chloride. J Am Geriatr Soc 1998 46 : 8 13.
12. Hill J, Fillit H, Thomas SK et al. Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias. Pharmacoeconomics 2006 24 : 265 2006;24:265-280.
13. Fick DM, Cooper JW, Wade WE et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts. Arch Intern Med 2003 163 : 2716 2724.
14. Mauskopf JA, Paramore C, Lee WC et al. Drug persistency patterns for patients treated with rivastigmine or donepezil in usual care settings. J Manag Care Pharm 2005 11 : 231 251.
15. Morris JN, Fries BE, Morris SA. Scaling adls within the MDS. J Gerontol A Biol Sci Med Sci 1999 54A : M546 M553.
16. Hartmaier SL, Sloane PD, Guess HA et al. The MDS cognition scale: A valid instrument for identifying and staging nursing home residents with dementia using the minimum data set. J Am Geriatr Soc 1994 42 : 1173 1179.
17. Gruber-Baldini AL, Zimmerman SI, Mortimore E et al. The validity of the minimum data set in measuring the cognitive impairment of persons admitted to nursing homes. J Am Geriatr Soc 2000 48 : 1601 1606.
18. Charlson ME, Pompei P, Ales KL et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987 40 : 373 383.
19. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992 45 : 613 619.
20. Todorova A, Vonderheid-Guth B, Dimpfel W. Effects of tolterodine, trospium chloride, and oxybutynin on the central nervous system. J Clin Pharmacol 2001 41 : 636 644.
21. Kay GG, Granville LJ. Antimuscarinic agents: Implications and concerns in the management of overactive bladder in the elderly. Clin Ther 2005 27 : 127 138.
22. Ouslander JG. Management of overactive bladder. N Engl J Med 2004 350 : 786 799.
23. Ancelin ML, Artero S, Portet F et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: Longitudinal cohort study. BMJ 2006 332 : 455 459.
24. Agostini JV, Leo-Summers LS, Inouye SK. Cognitive and other adverse effects of diphenhydramine use in hospitalized older patients. Arch Intern Med 2001 161 : 2091 2097.
25. Trinh NH, Hoblyn J, Mohanty S et al. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: A meta-analysis. JAMA 2003 289 : 210 216.
26. Caccamo A, Oddo S, Billings LM et al. M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 2006 49 : 671 682.
27. Perry EK, Kilford L, Lees AJ et al. Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. Ann Neurol 2003 54 : 235 238.
28. Black SA, Rush RD. Cognitive and functional decline in adults aged 75 and older. J Am Geriatr Soc 2002 50 : 1978 1986.
29. Njegovan V, Hing MM, Mitchell SL et al. The hierarchy of functional loss associated with cognitive decline in older persons. J Gerontol A Biol Sci Med Sci 2001 56A : M638 M643.
30. guero-Torres H, Fratiglioni L, Guo Z et al. Dementia is the major cause of functional dependence in the elderly: 3-year follow-up data from a population-based study. Am J Public Health 1998 88 : 1452 1456.
31. Kavirajan H, Schneider LS. Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: A meta-analysis of randomised controlled trials. Lancet Neurol 2007 6 : 782 792.
32. Burns A, O'Brien J, Auriacombe S et al. Clinical practice with anti-dementia drugs: A consensus statement from British Association for Psychopharmacology. J Psychopharmacol 2006 20 : 732 755.
33. Kay GG, Abou-Donia MB, Messer WS Jr. et al. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc 2005 53 : 2195 2201.
34. Kaduszkiewicz H, Zimmermann T, Beck-Bornholdt HP et al. Cholinesterase inhibitors for patients with Alzheimer's disease: Systematic review of randomised clinical trials. BMJ 2005 331 : 321 327.
35. Lanctot KL, Herrmann N, Yau KK et al. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: A meta-analysis. Can Med Assoc J 2003 169 : 557 564.
36. Herbison P, Hay-Smith J, Ellis G et al. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: Systematic review. BMJ 2003 326 : 841 844.
37. Gibbs CF, Johnson TM, Ouslander JG. Office management of geriatric urinary incontinence. Am J Med 2007 120 : 211 220.
38. Yap P, Tan D. Urinary incontinence in dementia - a practical approach. Aust Fam Physician 2006 35 : 237 241.